Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Gefitinib with Pemetrexed/Platinum in Advanced NSCLC
NCT01769066Phase 3Completed
- Sponsor
- Fudan University
- Start
- Dec 2009
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gefitinib in non-small cell lung cancer (NSCLC), sponsored by Fudan University. Started Dec 2009; status: completed.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01769066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01769066.